INSTIL BIO, INC.

Profile

Company Names

INSTIL BIO, INC.

Addresses

3963 MAPLE AVENUE, SUITE 350, DALLAS, TX 75219

5949 SHERRY LANE, SUITE 820, DALLAS, TX 75225

Phone Numbers

240-676-3715

 

Entity Type:

CORPORATION

Industry:

BIOTECHNOLOGY

Year Incorporated:

2018

State Incorporated:

DELAWARE

Total Amount Raised:

$381,165,771.00

Number of Funding Rounds:

4
Investment Rounds
Round #
Round Open Date
Amount Raised
Total Round Size
Amount Remaining to be Raised
Securities
4
2020-12-30 
$185,449,881.00 
$185,449,881.00 
$0.00 
Equity 
3
2020-06-30 
$170,199,973.00 
$170,199,973.00 
$0.00 
Equity 
2
2019-09-06 
$515,917.00 
$515,917.00 
$0.00 
Equity 
1
2019-03-04 
$25,000,000.00 
$25,000,000.00 
$0.00 
Equity 
People
First Name
Middle Name
Last Name
Titles
Related Companies
GWEN 
 
BINDER 
DIRECTOR
INSTIL BIO, INC.
BRONSON 
 
CROUCH 
EXECUTIVE OFFICER, DIRECTOR
ONCOLOGY INVESTORS OF TEXAS COSTIM, LLC   |  CURATIVE VENTURES VI LLC   |  INSTIL BIO, INC.
NEIL 
 
GIBSON 
DIRECTOR
REGULUS THERAPEUTICS INC.   |  SHATTUCK LABS, INC.   |  INSTIL BIO, INC.   |  CAUSEWAY THERAPEUTICS LTD
ROBERT 
 
HAWKINS 
DIRECTOR
INSTIL BIO, INC.
SANDEEP 
 
LAUMAS 
EXECUTIVE OFFICER
BEARING CIRCLE MILLENIUM FUND, LP   |  GLOBAVIR BIOSCIENCES INC.   |  INNOVATE BIOPHARMACEUTICALS INC.   |  BEARING CIRCLE MILLENNIUM FUND LP   |  INNOVATE BIOPHARMACEUTICALS, INC.   |  IB PHARMACEUTICALS INC.   |  UNICYCIVE THERAPEUTICS, INC.   |  9 METERS BIOPHARMA, INC.   |  INSTIL BIO, INC.   |  INVEA THERAPEUTICS, INC
GEORGE 
 
MATCHAM 
DIRECTOR
INSTIL BIO, INC.
KENT 
 
MCGAUGHY 
DIRECTOR
REATA PHARMACEUTICALS INC   |  MANDIANT CORP   |  INSTIL BIO, INC.   |  GRIFFIN HIGHLINE CAPITAL LLC
MARIAM 
 
MORRIS 
EXECUTIVE OFFICER
CERECOR INC.   |  INSTIL BIO, INC.
JACK 
 
NIELSEN 
DIRECTOR
PROTEIN FOREST, INC.   |  ALIOS BIOPHARMA INC   |  NEOMEND INC   |  APOLLO ENDOSURGERY INC   |  BIOCLIN THERAPEUTICS, INC.   |  UNCHAINED LABS   |  KANYOS BIO, INC.   |  PROCEPT BIOROBOTICS CORP   |  APOLLO ENDOSURGERY US INC   |  HARMONY BIOSCIENCES II, INC.   |  MACULOGIX, INC.   |  ALIGOS THERAPEUTICS, INC.   |  INSTIL BIO, INC.   |  OCELOT BIO, INC.   |  VIVO INNOVATION FUND II, L.P.   |  INSPIRNA, INC.   |  MANAT BIO, INC.
MARGO 
 
ROBERTS 
DIRECTOR
INSTIL BIO, INC.   |  LYELL IMMUNOPHARMA, INC.
NIMISH 
 
SHAH 
DIRECTOR
VENROCK HEALTHCARE CAPITAL PARTNERS III, L.P.   |  INSTIL BIO, INC.
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
2021-02-23
D
Link
BIOTECHNOLOGY 
BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836] 
DECLINE TO DISCLOSE 
Equity 
2020-12-30 
2020-08-05
D/A
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-03-04 
2020-08-05
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-09-06 
2020-08-05
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2020-06-30 
2019-09-30
D
Link
BIOTECHNOLOGY 
 
DECLINE TO DISCLOSE 
Equity 
2019-03-04 
Brokers
Broker Dealer
Broker CRD#
Recipient Name
Recipient CRD#